Evidence map›Paper›PMID 40085014›Full record

ArticleJournal of neuropathology and experimental neurology2025

Persistent increase of Nogo-A-positive cells and dynamic reduction in oligodendroglia lineage cells in white matter regions following experimental and clinical traumatic brain injury.

Karsten Ruscher, Georgios Michalettos, Sami Abu Hamdeh, Fredrik Clausen, Amber L Nolan, Johanna Flygt, Ilknur Özen, Niklas Marklund

Abstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Diffuse traumatic brain injury in mice is associated with a transient mismatch of cerebral blood flow and energy metabolism.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karsten RuscherDepartment of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden.ORCID 0000-0001-7211-2499
Georgios MichalettosDepartment of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden.
Sami Abu HamdehDepartment of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.
Fredrik ClausenDepartment of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.
Amber L NolanDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Johanna FlygtDepartment of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.
Ilknur ÖzenDepartment of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden.
Niklas MarklundDepartment of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden.

Funding

Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
Data Coordinating CoreU54NS115322 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SMITH, DOUGLAS HAMILTON, STEWART, WILLIAM · 2019 to 2023
$9.2M
Neuroimaging and clinical Endpoints With High-dimensional analysis Of Pathological Endophenotypes in TBI (NEW-HOPE-TBI)U01NS137484 · NINDS · UNIVERSITY OF WASHINGTON · PI CHRISTOPHER DIRK KEENE, Christine L MacDonald · 2024 to 2026
$6.3M
Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI (TRANSFORM-TBI)U01NS137500 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Edward Byung-Ha Lee, Douglas Hamilton Smith · 2024 to 2026
$5.8M
Alborada TrustCrafoord FoundationHans-GabrielHans-Gabriel and Trolle Wachtmeister FoundationNIA NIH HHS P30 AG066509NIA NIH HHS U01 AG006781NINDS NIH HHS U01 NS137484NINDS NIH HHS U01 NS137500NINDS NIH HHS U54 NS115322Skåne University HospitalSkåne University Hospital ALFSwedish Brain FoundationSwedish Research CouncilTrolle Wachtmeister Foundation
6 · The paper itself

Abstract

White matter (WM) disruption and atrophy is a consequence of traumatic brain injury (TBI) and contributes to persisting cognitive impairment. An increased expression of the myelin-associated axonal outgrowth inhibitor Nogo-A and oligodendrocyte pathology might be negatively associated with postinjury WM changes. Here, we analyzed brain tissue from severe TBI patients, obtained by surgical decompression in the early postinjury phase and postmortem brain tissue of long-term TBI survivors and observed an increased number of Nogo-A+ cells in WM tracts such as the corpus callosum (CC). Likewise, the number of Nogo-A+ cells in the CC was increased from day 7 postinjury to 6 months postinjury (mpi) following central fluid percussion injury (cFPI) in mice. In addition, the number of Olig2+ cells in the CC and capsula externa remained constant, while the numbers of Olig2+/CC1+ and GST-π+ mature oligodendrocytes declined throughout the observation time of 18 months. A significantly lower number of Olig2+/CC1+ cells was found in cFPI mice compared to controls at 18 mpi. Persistent vulnerability of oligodendrocytes in combination with dynamic alterations of Nogo-A expression may have implications for the WM atrophy and insufficient recovery observed after TBI.

Indexed as

Brain Injuries, TraumaticNogo ProteinsOligodendrogliaWhite MatterAdultAnimalsCell LineageFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedNogo ProteinsRTN4 protein, humancentral fluid percussion injurylong-term recoveryNogo-Aoligodendrocytetraumatic brain injury

Identifiers

PMID40085014
PMCPMC12012378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.